Related Experiment Video
Updated: Aug 11, 2026
09:59
An “All-laser” Endothelial Transplant
Published on: July 6, 2015
[Laser's biostimulation in healing or crural ulcerations]
P Król1, A Franek, W Huńka-Zurawińska
1Katedra i Zakład Biofizyki Lekarskiej Slaskiej Akademii Medycznej w Katowicach.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|February 21, 2002
Summary
Laser biostimulation using an 810 nm laser showed no significant difference in healing venous crural ulcerations compared to placebo. While ulcer size decreased in all groups, laser therapy did not offer a statistically significant advantage for ulcer volume reduction.
Area of Science:
- Medical Science
- Biomedical Engineering
Background:
- Venous crural ulcerations represent a significant clinical challenge.
- Effective treatment strategies for chronic wound healing are continuously sought.
Purpose of the Study:
- To evaluate the efficacy of laser biostimulation in healing venous crural ulcerations.
- To compare laser therapy outcomes against pharmacological and compress therapy alone, and a placebo control.
Main Methods:
- A randomized controlled trial involving three groups (A, B, C) of patients with venous crural ulcerations.
- Group A received pharmacological treatment, compress therapy, and 810 nm laser biostimulation (4 J/cm2).
- Group B received pharmacological treatment, compress therapy, and a placebo (quasi-laserotherapy). Group C received only pharmacological treatment and compress therapy.
Main Results:
- All groups demonstrated a statistically significant decrease in ulcer size post-treatment.
- No statistically significant difference in ulcer size reduction was observed between the groups.
- A statistically significant decrease in ulcer volume was noted in groups A and C, but not between the groups.
Conclusions:
- Standard pharmacological and compress therapy are effective in reducing the size of venous crural ulcerations.
- Laser biostimulation at 810 nm did not provide a statistically significant additional benefit for ulcer size or volume reduction compared to placebo or standard care.
